ASCO in Action

ASCO in Action provides the latest news and analysis related to critical policy issues affecting the cancer community, updates on the Association for Clinical Oncology’s ongoing advocacy efforts, and opportunities for members and others in the cancer care community to take action.

To sign up for advocacy alerts, log in to ASCO.org with your member or guest account, and visit the subscription center available under your account profile.

Tune in to the ASCO in Action podcast series for analysis and commentary on cancer policy and practice issues. The podcast is available through iTunes or Google Play.

Showing results for Policy

October 16, 2020

Oncology providers familiar with the American Society of Clinical Oncology’s (ASCO) guideline on older adults with cancer are two to four times more likely to conduct a geriatric assessment on patients with cancer over the age of 65, according to the first international ASCO survey aimed at determining if and how often cancer providers are using geriatric assessments when treating older adults. This is a noteworthy finding, according to ASCO, because nearly 70% of patients with cancer in the United States are 65 years of age or older, and globally, the number of new cancer cases per year among older adults will exceed 13 million by 2030.

September 1, 2020

On Monday, August 23, ASCO President Lori J. Pierce, MD, FASTRO, FASCO, and Stand Up To Cancer (SU2C) Health Equity Committee Chair Edith Perez, MD, met virtually to discuss the importance of health equity and the work ASCO and Stand Up To Cancer are doing to increase diversity in cancer research and treatment.

September 1, 2020

On September 17, the American Society of Clinical Oncology (ASCO) will host ASCO Practice Leadership: E&M Codes For 2021. During this free webinar, Allison Hirschorn, Senior Coding and Reimbursement Specialist, Clinical Affairs at ASCO, will review new information and changes regarding the office and outpatient Evaluation and Management (E&M) services Current Procedural Terminology (CPT ®) codes (99202-99215), which go into effect January 1, 2021.

August 27, 2020

The American Society of Clinical Oncology (ASCO) released its 2020 Workforce Information Systems (WIS) report, which assembles the latest available data on oncologist supply and demand in the United States to provide a close look at a critical segment of the workforce who care for people with cancer.

August 21, 2020

Reducing the risk for skin cancer requires targeted strategies in four areas, a policy statement from the American Society of Clinical Oncology reports. The statement, published online in May and in the August print edition of JCO Oncology Practice, makes recommendations on the prevention of the three most prominent skin cancers, melanoma, basal cell carcinoma, and squamous cell carcinoma, across four core areas: indoor tanning, sun-protection promotion, community education and outreach, and the role of the oncology provider.

August 18, 2020

American Society of Clinical Oncology (ASCO) President Lori J. Pierce, MD, FASTRO, FASCO, and American Cancer Society Cancer Action Network (ACS CAN) President Lisa A. Lacasse, MBA, contributed an editorial for Urban One’s Engaging Black America issue, where they discuss the need to prioritize policy solutions that address systemic health disparities.

August 14, 2020

The American Society of Clinical Oncology released today a position statement that recommends specific actions for applying telemedicine in cancer care during the pandenic and after its expiration. 

August 12, 2020

One of the nation’s leading cancer organizations today called for new actions to reduce disparities in cancer outcomes affecting racial and ethnic minorities, rural populations, sexual and gender minorities, people without insurance, and other disadvantaged populations. In a policy statement published in the Journal of Clinical Oncology (JCO), the American Society of Clinical Oncology (ASCO) argues that while progress has been made in raising awareness of disparities and driving research, the cancer community needs to take bolder, more aggressive steps to achieve equity for all patients.

August 6, 2020

On August 20, the American Society of Clinical Oncology (the Society), and its affiliate organization the Association for Clinical Oncology (the Association), will host ASCO Practice Leadership: 2021 MPFS & OPPS Rules, a free webinar that will review the 2021 Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment System (OPPS) proposed rules.

July 30, 2020

The American Society of Clinical Oncology (ASCO) released a position statement that raises concerns about home infusion of anticancer therapy and Centers for Medicare & Medicaid Services (CMS) regulations regarding the practice. 

July 23, 2020

COVID-19 data collection efforts by the American Society of Clinical Oncology (ASCO) were featured in three separate abstracts during the Association for Cancer Research (AACR) Virtual Meeting: COVID-19 and Cancer this week. Two of the abstracts highlighted COVID-19 data from PracticeNET, and one abstract that was selected for an oral presentation reported on the ASCO Survey on COVID-19 in Oncology (ASCO) Registry.

July 21, 2020

The American Society of Clinical Oncology (ASCO) and Association of Community Cancer Centers (ACCC) today announced a new collaboration to foster participation in cancer treatment trials to more fully reflect the diversity of people at risk for or living with cancer.

July 21, 2020

The US Food and Drug Administration (FDA) recently finalized four new final Guidance for Industry documents for cancer clinical trial eligibility criteria that describe ways that clinical trials can safely include patients who have historically been excluded. The guidance documents complement ongoing work by ASCO and Friends of Cancer Research (Friends) to eliminate overly restrictive eligibility criteria that can exclude patients from trials without scientific or participant safety justification. Clinical trials provide patients with cancer access to promising investigational therapies – which are sometimes the only treatment option available – and advance clinical care by producing safety and efficacy data about new therapies.

July 13, 2020

Following the completion of the 2020 Merit-based Incentive Payment System (MIPS) reporting year, the  American Society of Clinical Oncology (ASCO) will no longer offer MIPS reporting through the QOPI®  Reporting Registry, ASCO’s Qualified Clinical Data Registry (QCDR). 

July 6, 2020

On June 23, 2020, The U.S. District Court for the District of Columbia upheld a Trump administration policy requiring hospitals and health insurers to publish their negotiated rates for health services. The policy, which aims to increase transparency in U.S. healthcare system, is scheduled to go into effect on January 1, 2021.

Pages